Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
127.7 USD | +0.11% | -1.98% | +16.99% |
05-02 | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.99% | 323B | |
+31.23% | 662B | |
+21.96% | 546B | |
-5.32% | 359B | |
+4.72% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.09% | 167B | |
-2.20% | 157B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck Prices $8 Billion Senior Notes Offering